Chemours Net Debt Growth & History (CC)
Chemours's net debt was $3.76B for fiscal 2025.
View full Chemours company overviewChemours annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.76B | $65.0M | +1.76% |
| 2024 | 2024-12-31 | $3.70B | $542.0M | +17.17% |
| 2023 | 2023-12-31 | $3.16B | $317.0M | +11.17% |
| 2022 | 2022-12-31 | $2.84B | $231.0M | +8.86% |
| 2021 | 2021-12-31 | $2.61B | −$638.0M | −19.65% |
| 2020 | 2020-12-31 | $3.25B | −$341.0M | −9.51% |
| 2019 | 2019-12-31 | $3.59B | $814.0M | +29.35% |
| 2018 | 2018-12-31 | $2.77B | $214.0M | +8.36% |
| 2017 | 2017-12-31 | $2.56B | −$86.0M | −3.25% |
| 2016 | 2016-12-31 | $2.65B | −$943.0M | −26.28% |
| 2015 | 2015-12-31 | $3.59B | $3.59B | — |
| 2014 | 2014-12-31 | $0 | — | — |
Chemours quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.49B | −$457.0M | −11.58% |
| Q1 2026 | 2026-03-31 | $3.86B | −$97.0M | −2.45% |
| Q4 2025 | 2025-12-31 | $3.76B | $65.0M | +1.76% |
| Q3 2025 | 2025-09-30 | $3.84B | $98.0M | +2.62% |
| Q2 2025 | 2025-06-30 | $3.95B | $263.0M | +7.14% |
| Q1 2025 | 2025-03-31 | $3.96B | $392.0M | +10.99% |
| Q4 2024 | 2024-12-31 | $3.70B | $542.0M | +17.17% |
| Q3 2024 | 2024-09-30 | $3.74B | $297.0M | +8.62% |
| Q2 2024 | 2024-06-30 | $3.68B | $470.0M | +14.63% |
| Q1 2024 | 2024-03-31 | $3.57B | $432.0M | +13.78% |
| Q4 2023 | 2023-12-31 | $3.16B | $317.0M | +11.17% |
| Q3 2023 | 2023-09-30 | $3.44B | $773.0M | +28.94% |
| Q2 2023 | 2023-06-30 | $3.21B | $485.0M | +17.78% |
| Q1 2023 | 2023-03-31 | $3.14B | $258.0M | +8.96% |
| Q4 2022 | 2022-12-31 | $2.84B | $231.0M | +8.86% |
| Q3 2022 | 2022-09-30 | $2.67B | −$459.0M | −14.66% |
| Q2 2022 | 2022-06-30 | $2.73B | −$452.0M | −14.21% |
| Q1 2022 | 2022-03-31 | $2.88B | −$429.0M | −12.97% |
| Q4 2021 | 2021-12-31 | $2.61B | −$638.0M | −19.65% |
| Q3 2021 | 2021-09-30 | $3.13B | −$352.0M | −10.11% |
| Q2 2021 | 2021-06-30 | $3.18B | −$482.0M | −13.16% |
| Q1 2021 | 2021-03-31 | $3.31B | −$370.0M | −10.06% |
| Q4 2020 | 2020-12-31 | $3.25B | −$341.0M | −9.51% |
| Q3 2020 | 2020-09-30 | $3.48B | −$366.0M | −9.51% |
| Q2 2020 | 2020-06-30 | $3.66B | −$319.0M | −8.01% |
| Q1 2020 | 2020-03-31 | $3.68B | $53.0M | +1.46% |
| Q4 2019 | 2019-12-31 | $3.59B | $814.0M | +29.35% |
| Q3 2019 | 2019-09-30 | $3.85B | $1.12B | +41.16% |
| Q2 2019 | 2019-06-30 | $3.98B | $1.22B | +44.34% |
| Q1 2019 | 2019-03-31 | $3.62B | $901.0M | +33.09% |
| Q4 2018 | 2018-12-31 | $2.77B | $214.0M | +8.36% |
| Q3 2018 | 2018-09-30 | $2.73B | $163.0M | +6.36% |
| Q2 2018 | 2018-06-30 | $2.76B | $214.0M | +8.41% |
| Q1 2018 | 2018-03-31 | $2.72B | $66.0M | +2.48% |
| Q4 2017 | 2017-12-31 | $2.56B | −$86.0M | −3.25% |
| Q3 2017 | 2017-09-30 | $2.56B | −$225.0M | −8.07% |
| Q2 2017 | 2017-06-30 | $2.54B | −$932.0M | −26.81% |
| Q1 2017 | 2017-03-31 | $2.66B | −$862.0M | −24.50% |
| Q4 2016 | 2016-12-31 | $2.65B | −$943.0M | −26.28% |
| Q3 2016 | 2016-09-30 | $2.79B | −$959.0M | −25.59% |
| Q2 2016 | 2016-06-30 | $3.48B | −$220.0M | −5.95% |
| Q1 2016 | 2016-03-31 | $3.52B | — | — |
| Q4 2015 | 2015-12-31 | $3.59B | $3.59B | — |
| Q3 2015 | 2015-09-30 | $3.75B | — | — |
| Q2 2015 | 2015-06-30 | $3.70B | — | — |
| Q4 2014 | 2014-12-31 | $0 | — | — |
Chemours net debt trends
Over the last five fiscal years, Chemours's net debt increased from $3.25B to $3.76B, a change of $517.0M. The latest reported quarter, Q2 2026, shows $3.49B.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...